Skoner D P, Doyle W J, Seroky J, Van Deusen M A, Fireman P
Dept of Pediatrics, University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, PA 15213, USA.
Eur Respir J. 1996 Jul;9(7):1402-6. doi: 10.1183/09031936.96.09071402.
Acute asthma is considered to be a complication of respiratory viral infections. This investigation assessed the effects of rhinovirus 39 (RV-39) infection both on the patency and responsiveness of the lower airways. Subjects with allergic rhinitis (AR; n = 50) and without AR (non-AR; n = 46) were intranasally inoculated with RV-39, and monitored for 8 days in an enclosed environment for changes in symptoms, signs, and airway physiology (pulmonary function, bronchial methacholine provocation). All subjects were infected postinoculation. Significant increases in nasal symptoms and secretion weights were observed, with peak effects on days 2-3. Cough was a relatively minor symptom and none of the subjects developed wheezing. Likewise, there were no significant changes in the measured functions of the lower airways. No allergy status effects were observed. Under these experimental conditions, rhinovirus 39 infection did not produce detectable alterations in lower airway function in healthy subjects with and without allergic rhinitis.
急性哮喘被认为是呼吸道病毒感染的一种并发症。本研究评估了鼻病毒39(RV - 39)感染对下呼吸道通畅性和反应性的影响。将患有变应性鼻炎(AR;n = 50)和未患变应性鼻炎(非AR;n = 46)的受试者经鼻接种RV - 39,并在封闭环境中监测8天,观察症状、体征和气道生理学(肺功能、支气管乙酰甲胆碱激发试验)的变化。所有受试者接种后均被感染。观察到鼻部症状和分泌物重量显著增加,在第2 - 3天达到峰值效应。咳嗽是相对较轻的症状,且没有受试者出现喘息。同样,下呼吸道的测量功能也没有显著变化。未观察到过敏状态的影响。在这些实验条件下,RV - 39感染在患有和未患变应性鼻炎的健康受试者中未引起下呼吸道功能的可检测改变。